title: Successful use of reduced-intensity conditioning and matched-unrelated hematopoietic stem cell transplant in a child with Diamond-Blackfan anemia and cirrhosis.
abstract: For patients with DBA who are transfusion dependent, HSCT is the only cure. Chronic transfusions can lead to cirrhosis secondary to iron overload, making them poor candidates for myeloablative HSCT. RIC regimens are associated with lower morbidity and mortality compared to myeloablative regimens, but use of RIC in DBA has been limited. Here we present a 14-yr-old girl with DBA and multiple comorbidities including liver cirrhosis, who underwent MUD HSCT utilizing a RIC regimen that is novel to this condition. She tolerated the regimen well, and at 21 months, she remains transfusion independent with chimerisms at 99%.
authors.affiliation: Department of Pediatrics, Nationwide Children's Hospital, Columbus, OH, USA.|Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
authors.forename: Justin M
authors.initials: JM
authors.lastname: Asquith
authors.affiliation: Department of Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, OH, USA.
authors.forename: Jessica
authors.initials: J
authors.lastname: Copacia
authors.affiliation: Department of Pediatric Hematology and Oncology, Marshall University School of Medicine, Huntington, WV, USA.
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Mogul
authors.affiliation: Department of Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, OH, USA.
authors.forename: Rajinder P S
authors.initials: RP
authors.lastname: Bajwa
mesh_terms: D000293:Adolescent; D029503:Anemia, Diamond-Blackfan / Q000150:complications / Q000628:therapy*; D017707:Erythrocyte Transfusion / Q000009:adverse effects; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D008103:Liver Cirrhosis / Q000209:etiology*; D019172:Transplantation Conditioning / Q000379:methods*
keywords: Diamond-Blackfan anemia; cirrhosis; hematopoietic stem cell transplant; hemochromatosis; hereditary bone marrow failure; matched-unrelated donor; reduced-intensity conditioning